Cargando…
Serum galectin-1 in patients with multiple myeloma: associations with survival, angiogenesis, and biomarkers of macrophage activation
Galectin-1 (Gal-1) is known to regulate cell signaling within the immune system and may be a target for new anticancer immune therapy. In patients with chronic lymphocytic leukemia (CLL) and classical Hodgkin lymphoma (cHL), high levels of Gal-1 within the tumor microenvironment were associated with...
Autores principales: | Andersen, Morten Nørgaard, Ludvigsen, Maja, Abildgaard, Niels, Petruskevicius, Irma, Hjortebjerg, Rikke, Bjerre, Mette, Honoré, Bent, Møller, Holger J, Andersen, Niels F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5388249/ https://www.ncbi.nlm.nih.gov/pubmed/28435287 http://dx.doi.org/10.2147/OTT.S124321 |
Ejemplares similares
-
Multiple Myeloma Associated Bone Disease
por: Rasch, Stine, et al.
Publicado: (2020) -
The STC2–PAPP-A–IGFBP4–IGF1 axis and its associations to mortality and CVD in T2D
por: Gude, Mette Faurholdt, et al.
Publicado: (2023) -
Identification and characterization of endonuclein binding proteins: evidence of modulatory effects on signal transduction and chaperone activity
por: Ludvigsen, Maja, et al.
Publicado: (2009) -
Physical function in patients newly diagnosed with multiple myeloma; a Danish cohort study
por: Larsen, Rikke Faebo, et al.
Publicado: (2020) -
SAT-046 Insulin-Like Growth Factor and Fibroblast Growth Factor 21 in Men with Klinefelter Syndrome
por: Chang, Simon, et al.
Publicado: (2020)